EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Selective Inhibition of PI3K Isoforms in Brain Tumors Suppresses Tumor Growth by Increasing Radiosensitivity

Mi Youn Seol iD, Seo Hee Choi iD, Ik Jae Lee iD, Hyung Soon Park iD, Hye Ryun Kim iD, Sang Kyum Kim iD, Hong In Yoon iD

Yonsei Medical Journal · 2023

DOI: 10.3349/ymj.2022.0414 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Yonsei Medical Journal, 2023. Verfasst von Mi Youn Seol und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Yonsei Cancer Center, Heavy Ion Therapy Research Institute, Yonsei University College of Medicine, Seoul, Korea. Hauptthemen laut MEDLINE: Brain Neoplasms, Glioblastoma. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Research Foundation of Korea.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Brain NeoplasmsGlioblastomaAnimalsMiceProto-Oncogene Proteins c-aktPhosphatidylinositol 3-KinasesPhosphatidylinositol 3-KinaseCell Line, TumorRadiation TolerancePhosphoinositide-3 Kinase InhibitorsProtein IsoformsApoptosis

Stichwörter der Autor:innen

GlioblastomaPI3K-isoformradiationradioresistanceradiosensitivity

Substanzen

Proto-Oncogene Proteins c-aktPhosphatidylinositol 3-KinasesPhosphatidylinositol 3-KinasePhosphoinositide-3 Kinase InhibitorsProtein Isoforms

Autor:innen und Institutionen

  • Department of Radiation Oncology, Yonsei Cancer Center, Heavy Ion Therapy Research Institute, Yonsei University College of Medicine, Seoul, Korea.
  • Department of Radiation Oncology, Yongin Severance Hospital, Yonsei University College of Medicine, Yongin, Korea.
  • Division of Medical Oncology, Department of Internal Medicine, St. Vincent's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.
  • Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.
  • Department of Pathology, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.
  • Department of Radiation Oncology, Yonsei Cancer Center, Heavy Ion Therapy Research Institute, Yonsei University College of Medicine, Seoul, Korea. YHI0225@yuhs.ac.

ORCID-Profile: Mi Youn Seol, Seo Hee Choi, Ik Jae Lee, Hyung Soon Park, Hye Ryun Kim, Sang Kyum Kim, Hong In Yoon

Förderung

  • National Research Foundation of Korea

Zitieren

APA

Seol, M. Y., Choi, S. H., Lee, I. J., Park, H. S., Kim, H. R., Kim, S. K., & Yoon, H. I. (2023). Selective Inhibition of PI3K Isoforms in Brain Tumors Suppresses Tumor Growth by Increasing Radiosensitivity. Yonsei Medical Journal. https://doi.org/10.3349/ymj.2022.0414

Vancouver

Seol MY, Choi SH, Lee IJ, Park HS, Kim HR, Kim SK, et al. Selective Inhibition of PI3K Isoforms in Brain Tumors Suppresses Tumor Growth by Increasing Radiosensitivity. Yonsei Medical Journal. 2023. doi:10.3349/ymj.2022.0414

BibTeX
@article{Seol2023,
  author = {Seol, Mi Youn and Choi, Seo Hee and Lee, Ik Jae and Park, Hyung Soon and Kim, Hye Ryun and Kim, Sang Kyum and Yoon, Hong In},
  title = {Selective Inhibition of PI3K Isoforms in Brain Tumors Suppresses Tumor Growth by Increasing Radiosensitivity},
  journal = {Yonsei Medical Journal},
  year = {2023},
  doi = {10.3349/ymj.2022.0414}
}
Kostenlos starten →